CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +710,711 | 710,711 | ||
| 2021-07-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +379,788 | 379,788 | ||
| 2020-07-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +179,785 | 179,785 | ||
| 2020-05-29 | Noble James Director | Sale | −500,000 | $9.33 | $4.7M | 0 |
| 2020-04-01 | Noble James Director | Grant or award · Option to purchase Ordinary Shares | +31,000 | 31,000 | ||
| 2020-01-13 | Noble James Director | Sale | −100,000 | $4.00 | $400K | 0 |
| 2020-01-13 | Noble James Director | Sale | −200,000 | $5.00 | $1.0M | 0 |
| 2019-05-16 | Noble James Chief Executive Officer | Option exercise | +1,773,100 | $0.14 | $254K | 1,773,100 |
| 2019-01-04 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +2,515,536 | 2,515,536 | ||
| 2019-01-04 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +561,792 | 561,792 | ||
| 2018-01-12 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,719,936 | 1,719,936 | ||
| 2018-01-12 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +384,120 | 384,120 | ||
| 2017-01-13 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +2,072,976 | 2,072,976 | ||
| 2016-01-18 | Noble James Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,968,016 | 1,968,016 |
Page 1 of 1 · 14 trades